Unaudited interim condensed consolidated financial statements as at September 30, 2025 | ||||||||
| Valneva SE | ||||||||
| I. | Unaudited Interim Consolidated Statement of Profit or Loss and Comprehensive Income | ||||
| Nine months ended September 30, | ||||||||
| in € thousand | 2025 | 2024 | ||||||
| Product sales | ||||||||
| Other revenues | ||||||||
| REVENUES | ||||||||
| Cost of goods and services | ( | ( | ||||||
| Research and development expenses | ( | ( | ||||||
| Marketing and distribution expenses | ( | ( | ||||||
| General and administrative expenses | ( | ( | ||||||
| Gain from sale of Priority Review Voucher, net | ||||||||
| Other income and expenses, net | ||||||||
| OPERATING PROFIT/(LOSS) | ( | |||||||
| Finance income | ||||||||
| Finance expenses | ( | ( | ||||||
| Foreign exchange gain/(loss), net | ||||||||
| PROFIT/(LOSS) BEFORE INCOME TAX | ( | |||||||
| Income tax benefit/(expense) | ( | |||||||
| PROFIT/(LOSS) FOR THE PERIOD | ( | |||||||
| EARNINGS/(LOSSES) PER SHARE | ||||||||
for profit/(loss) for the period attributable to the equity holders of the Company (expressed in € per share) | ||||||||
| Basic | ( | |||||||
| Diluted | ( | |||||||
| Nine months ended September 30, | ||||||||
| in € thousand | 2025 | 2024 | ||||||
| PROFIT/(LOSS) FOR THE PERIOD | ( | |||||||
| OTHER COMPREHENSIVE INCOME/(LOSS) | ||||||||
| Items that may be reclassified to profit or loss | ||||||||
| Currency translation differences | ||||||||
| Items that will not be reclassified to profit or loss | ||||||||
| Defined benefit plan actuarial gains/(losses) | ( | |||||||
| Other comprehensive income/(loss) for the period, net of tax | ||||||||
| TOTAL COMPREHENSIVE INCOME/(LOSS) FOR THE PERIOD | ( | |||||||
2 | ||||||||||||||
Unaudited interim condensed consolidated financial statements as at September 30, 2025 | ||||||||
| Valneva SE | ||||||||
| II. | Unaudited Interim Condensed Consolidated Statement of Financial Position | ||||
| in € thousand | September 30, 2025 | December 31, 2024 | ||||||
| ASSETS | ||||||||
| Non-current assets | ||||||||
| Intangible assets | ||||||||
| Right of use assets | ||||||||
| Property, plant and equipment | ||||||||
| Deferred tax assets | ||||||||
| Other non-current assets | ||||||||
| Current assets | ||||||||
| Inventories | ||||||||
| Trade receivables | ||||||||
| Other current assets | ||||||||
| Cash and cash equivalents | ||||||||
| TOTAL ASSETS | ||||||||
| EQUITY | ||||||||
| Share capital | ||||||||
| Share premium | ||||||||
| Other reserves | ||||||||
| Retained earnings/(Accumulated deficit) | ( | ( | ||||||
| Profit/(Loss) for the period | ( | ( | ||||||
| TOTAL EQUITY | ||||||||
| LIABILITIES | ||||||||
| Non-current liabilities | ||||||||
| Borrowings | ||||||||
| Lease liabilities | ||||||||
| Refund liabilities | ||||||||
| Provisions | ||||||||
| Deferred tax liabilities | ||||||||
| Other non-current liabilities | ||||||||
| Current liabilities | ||||||||
| Borrowings | ||||||||
| Trade payables and accruals | ||||||||
| Income tax liability | ||||||||
| Tax and Employee-related liabilities | ||||||||
| Lease liabilities | ||||||||
| Contract liabilities | ||||||||
| Refund liabilities | ||||||||
| Provisions | ||||||||
| Other current liabilities | ||||||||
| TOTAL LIABILITIES | ||||||||
| TOTAL EQUITY AND LIABILITIES | ||||||||
3 | ||||||||||||||
Unaudited interim condensed consolidated financial statements as at September 30, 2025 | ||||||||
| Valneva SE | ||||||||
| III. | Unaudited Interim Condensed Consolidated Statement of Cash Flows | ||||
| Nine months ended September 30, | ||||||||
| in € thousand | 2025 | 2024 | ||||||
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Profit/(Loss) for the period | ( | |||||||
| Gain from sale of Priority Review Voucher, net | ( | |||||||
| Adjustments to reconcile profit/(loss) for the period to cash generated from/(used in) operations | ||||||||
| Changes in non-current operating assets and liabilities | ||||||||
| Changes in working capital | ( | |||||||
| Cash used in operations | ( | ( | ||||||
| Income tax paid | ( | ( | ||||||
| NET CASH GENERATED FROM/(USED IN) OPERATING ACTIVITIES | ( | ( | ||||||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Purchases of property, plant and equipment | ( | ( | ||||||
| Proceeds from sale of property, plant and equipment | ||||||||
| Purchases of intangible assets | ( | ( | ||||||
| Proceeds from sale of Priority Review Voucher | ||||||||
| Interest received | ||||||||
| NET CASH GENERATED FROM/(USED IN) INVESTING ACTIVITIES | ( | |||||||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Proceeds/(payments) from issuance of common stock, net of costs of equity transactions | ||||||||
| Proceeds from borrowings, net of transaction costs | ( | |||||||
| Repayment of borrowings | ( | ( | ||||||
| Payment of lease liabilities | ( | ( | ||||||
Interest paid 1 | ( | ( | ||||||
| NET CASH GENERATED FROM FROM/(USED IN) FINANCING ACTIVITIES | ||||||||
| NET CHANGE IN CASH AND CASH EQUIVALENTS | ( | |||||||
| Cash and cash equivalents at beginning of the year | ||||||||
| Exchange gains/(losses) on cash | ( | ( | ||||||
| CASH AND CASH EQUIVALENTS AT END OF THE PERIOD | ||||||||
4 | ||||||||||||||
Unaudited interim condensed consolidated financial statements as at September 30, 2025 | ||||||||
| Valneva SE | ||||||||
| IV. | Unaudited Interim Condensed Consolidated Statement of Changes in Equity | ||||
| in € thousand | Share capital | Share premium | Other reserves | Retained earnings/ (Accumulated deficit) | Profit/(loss) for the period | Total equity | ||||||||||||||
| BALANCE AS AT JANUARY 1, 2025 | ( | ( | ||||||||||||||||||
| Total comprehensive income/(loss) | — | — | — | ( | ( | |||||||||||||||
| Income appropriation | — | — | — | ( | ||||||||||||||||
| Share-based compensation expense: | ||||||||||||||||||||
| Value of services | — | — | — | — | ||||||||||||||||
| Exercises | — | — | — | — | — | |||||||||||||||
| Capital Increase | — | — | — | |||||||||||||||||
| Cost of equity transaction, net of tax | — | ( | — | — | — | ( | ||||||||||||||
| BALANCE AS AT SEPTEMBER 30, 2025 | ( | ( | ||||||||||||||||||
| in € thousand | Share capital | Share premium | Other reserves | Retained earnings/ (Accumulated deficit) | Profit/(loss) for the period | Total equity | ||||||||||||||
| BALANCE AS AT JANUARY 1, 2024 | ( | ( | ||||||||||||||||||
| Total comprehensive income/(loss) | — | — | — | |||||||||||||||||
| Income appropriation | — | — | — | ( | ||||||||||||||||
| Share-based compensation expense: | ||||||||||||||||||||
| Value of services | — | — | — | — | ||||||||||||||||
| Exercises | ( | — | — | — | ||||||||||||||||
| Capital Increase | — | — | — | |||||||||||||||||
| Cost of equity transaction, net of tax | — | ( | — | — | — | ( | ||||||||||||||
| BALANCE AS AT SEPTEMBER 30, 2024 | ( | |||||||||||||||||||
5 | ||||||||||||||